As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint
Executive Summary
Hi-Tech Pharmaceuticals granted motion in federal court to have $19m in seized DMAA products returned, though the order noted sales of the products are prohibited. As Hi-Tech seeks court order that FDA is wrong about DMAA, an appellate court upholds $40m contempt fine against firm in FTC complaint.
You may also be interested in...
Second Atlanta-Area Business Faces Criminal Charges Linked To Steroid-Spiked Supplements
CCB Nutrition owner pleads guilty in federal court to selling an unapproved new drug with the intent to defraud and mislead the FDA and consumers. Hi-Tech Pharmaceuticals CEO still faces criminal charges after Supreme Court refused his appeal after trial and appellate court rejected motion to dismiss an indictment alleging he distributed steroid-spiked supplements and falsified compliance documents.
US COVID-19 Claim Warnings Continue; Hi-Tech’s Problems Extend To Undeclared Allergens
Natural Adventure and PYRLess Group are latest firms to learn FDA, FTC continue monitoring the market for claims promoting supplements as COVID-19 treatments. Hi-Tech Pharmaceuticals recalls APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz due to undeclared allergens.
Supplement Firm Hi-Tech Pays For Another Round Of Refunds In FTC’s 15-Year Litigation
FTC is mailing 143,636 refund checks totaling more than $8.5m to consumers who bought three supplements marketed with false and misleading advertising by Hi-Tech Pharmaceuticals and several related companies.